Irish Life Investment Managers’s Pacira BioSciences PCRX Stock Holding History

Irish Life Investment Managers’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$49.3K	Buy	+1,700	New	+$49.2K	﹤0.01%	1394

Other funds holding PCRX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Irish Life Investment Managers's PCRX Position: Q2 2013 in Review

Irish Life Investment Managers opened a new position in Pacira BioSciences (PCRX) in Q2 2013: 1,700 shares worth $49.3K. The stake represents ﹤0.01% of the portfolio and ranks #1394 among its holdings.

116 funds tracked by Wall St. Rank hold PCRX as of Q2 2013.

Irish Life Investment Managers held 1,700 shares of Pacira BioSciences worth $49.3K as of Q2 2013.
Pacira BioSciences was a new Irish Life Investment Managers position in Q2 2013.
Pacira BioSciences made up ﹤0.01% of Irish Life Investment Managers's portfolio in Q2 2013, its #1394 holding.
116 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2013.

Based on Irish Life Investment Managers's 13F filing for Q2 2013, filed 13 Aug 2013.